| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK1325756 |
|---|
| Description | GSK1325756 is a selective and reversible CXCR2 antagonist with IC50 value of 12.5 nM. GSK1325756 displays anti-inflammatory effects in various preclinical and clinical models. MW: 441.9. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1-[4-chloro-2-hydroxy-3-[(3S)-piperidin-3-yl]sulfonylphenyl]-3-(3-fluoro-2-methylphenyl)urea; Danirixin |
|---|
| Gene, Accession, CAS # | CAS: 954126-98-8 |
|---|
| Catalog # | B1103-5 |
|---|
| Price | |
|---|
| Order / More Info | GSK1325756 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|